Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 28, 2024; 30(20): 2629-2632
Published online May 28, 2024. doi: 10.3748/wjg.v30.i20.2629
Published online May 28, 2024. doi: 10.3748/wjg.v30.i20.2629
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
Meer M Chisthi, Department of General Surgery, Government Medical College Pathanamthitta, Konni 689691, Kerala, India
Author contributions: Chisthi MM was responsible for all work on the manuscript.
Conflict-of-interest statement: Dr. Chisthi has nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Meer M Chisthi, MBBS, MS, Professor, Surgeon, Department of General Surgery, Government Medical College Pathanamthitta, Aanakuthi, Konni 689691, Kerala, India. meerchisthi@gmail.com
Received: March 2, 2024
Revised: April 22, 2024
Accepted: April 30, 2024
Published online: May 28, 2024
Processing time: 86 Days and 10.1 Hours
Revised: April 22, 2024
Accepted: April 30, 2024
Published online: May 28, 2024
Processing time: 86 Days and 10.1 Hours
Core Tip
Core Tip: The study introduces the Exercise and Diet Adherence Scale (EDAS), a robust tool for assessing patient adherence to lifestyle interventions in non-alcoholic fatty liver disease (NAFLD). Developed using the Delphi method, the EDAS consists of 33 items across six dimensions, offering a comprehensive evaluation. Results indicate its significant correlation with key lifestyle indicators, allowing for precise differentiation of adherence levels. Clinically relevant thresholds make the EDAS a practical and valuable instrument for identifying patients with poor adherence. This contribution holds promise for advancing NAFLD research and enhancing clinical interventions through a targeted focus on lifestyle adherence assessment.